Cipher Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Cipher Pharmaceuticals has a total shareholder equity of $80.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $86.0M and $5.5M respectively. Cipher Pharmaceuticals's EBIT is $10.3M making its interest coverage ratio -5.5. It has cash and short-term investments of $39.8M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -5.5x |
Cash | US$39.83m |
Equity | US$80.52m |
Total liabilities | US$5.51m |
Total assets | US$86.03m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPHR.F's short term assets ($48.3M) exceed its short term liabilities ($5.3M).
Long Term Liabilities: CPHR.F's short term assets ($48.3M) exceed its long term liabilities ($259.0K).
Debt to Equity History and Analysis
Debt Level: CPHR.F is debt free.
Reducing Debt: CPHR.F has no debt compared to 5 years ago when its debt to equity ratio was 71%.
Debt Coverage: CPHR.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CPHR.F has no debt, therefore coverage of interest payments is not a concern.